Skeith, Leslie

Hematologic Oncology

Assistant Professor

Biography

Dr. Leslie Skeith is an Assistant Professor and hematologist with a clinical and research interest in women’s health and venous thromboembolism (VTE). She is cross-appointed to the Department of Medicine, Community Health Sciences and Oncology, and is a member of the Libin Cardiovascular Research Institute of Alberta, O’Brien Institute for Public Health and the Alberta Children’s Hospital Research Institute. 

She is leading a CIHR-funded multinational pilot RCT evaluating the feasibility of aspirin to prevent VTE in postpartum women at risk of thrombosis (www.partumtrial.ca), and is also completing research in the area of antiphospholipid syndrome and pregnancy.

Area of Focus

Summary of Research

Andrew L, Ni Ainle, Blondon M, Rodger MA, Skeith L. Preventing postpartum venous thromboembolism: A call to action to reduce undue maternal morbidity and mortality. Thrombosis Research epub online July 2020.

Skeith L. Anticoagulating patients with high-risk acquired thrombophilias. Blood 2018;132:2219-2229.

Skeith L, Carrier M, Kaaja R, et al. A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia. Blood 2016;127:1605-1655.

Area Of Focus

Summary Of Research

Andrew L, Ni Ainle, Blondon M, Rodger MA, Skeith L. Preventing postpartum venous thromboembolism: A call to action to reduce undue maternal morbidity and mortality. Thrombosis Research epub online July 2020.

Skeith L. Anticoagulating patients with high-risk acquired thrombophilias. Blood 2018;132:2219-2229.

Skeith L, Carrier M, Kaaja R, et al. A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia. Blood 2016;127:1605-1655.